MICRUSFRAME (19+ models)— 510(k) K262419

Substantially Equivalent

Cerenovus, Inc.

FDA 510(k) clearance K262419 for MICRUSFRAME (19+ models), Substantially Equivalent on 2026-08-14. Applicant: Cerenovus, Inc.. Device class: 2.

Clearance details

Device name as filed
MICRUSFRAME (MFR100202); MICRUSFRAME (MFR100253); MICRUSFRAME (MFR100305); MICRUSFRAME (MFR100356); MICRUSFRAME (MFR100407); MICRUSFRAME (MFR100412); MICRUSFRAME (MFR100509); MICRUSFRAME (MFR100517); MICRUSFRAME (MFR100611); MICRUSFRAME (MFR100626); MICRUSFRAME (MFR100713); MICRUSFRAME (MFR100730); MICRUSFRAME (MFR100816); MICRUSFRAME (MFR100829); MICRUSFRAME (MFR140225); MICRUSFRAME (MFR140303); MICRUSFRAME (MFR140304); MICRUSFRAME (MFR140306); MICRUSFRAME (MFR140406); MICRUSFRAME (MF
Applicant
Cerenovus, Inc.
Product code
Code HCG
Device class
Class 2
Regulation
21 CFR 882.5950
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Irvine, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code HCG

view all

More clearances from Cerenovus, Inc.

view all

Adverse events under product code HCG

product code HCG
Death
50
Injury
801
Malfunction
5,625
Total
6,476

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.